Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine in Chronic Heart Failure
NCT00151619Phase 2Terminated
- Sponsor
- CHU Rennes
- Start
- Feb 1999
- Primary completion
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amlodipine in chronic heart failure (CHF) (3 arms), sponsored by CHU Rennes. Primary endpoint: Humeral blood flow at 3 months. Started Feb 1999; status: terminated.
02
Drugs
amlodipine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00151619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151619.